BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38195438)

  • 1. Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.
    Zhang L; Mei X; Hu Z; Yu B; Zhang C; Li Y; Liu K; Ma X; Ma J; Chen X; Meng J; Shi W; Wang X; Mo M; Shao Z; Zhang Z; Yu X; Guo X; Yang Z
    BMC Cancer; 2024 Jan; 24(1):49. PubMed ID: 38195438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Entire Versus Medial Supraclavicular Nodal Irradiation for Patients With High-Risk Node-Positive Breast Cancer.
    Zhang L; Liu J; Ma J; Mei X; Chen X; Mo M; Wang X; Meng J; Shi W; Bazan JG; Shao Z; Zhang Z; Yu X; Guo X; Yang Z
    Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):120-129. PubMed ID: 35654307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
    Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
    BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial.
    Xie J; Xu F; Zhao Y; Cai G; Lin X; Zhu Q; Lin Q; Yao Y; Xu C; Cai R; Wang S; Tang X; Chen C; Zheng S; Chen M; Chen M; Qian X; Shen C; Li J; Xu H; Xu F; Han Y; Li M; Ou D; Shen KW; Qi WX; Cao L; Huang X; Chen J
    BMJ Open; 2022 Sep; 12(9):e062034. PubMed ID: 36581983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy.
    Lee TH; Chang JH; Jang BS; Kim JS; Kim TH; Park W; Kim YB; Kim SS; Han W; Lee HB; Shin KH
    BMC Cancer; 2022 Nov; 22(1):1179. PubMed ID: 36384573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
    Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
    Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.
    Poortmans PM; Weltens C; Fortpied C; Kirkove C; Peignaux-Casasnovas K; Budach V; van der Leij F; Vonk E; Weidner N; Rivera S; van Tienhoven G; Fourquet A; Noel G; Valli M; Guckenberger M; Koiter E; Racadot S; Abdah-Bortnyak R; Van Limbergen EF; Engelen A; De Brouwer P; Struikmans H; Bartelink H;
    Lancet Oncol; 2020 Dec; 21(12):1602-1610. PubMed ID: 33152277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
    Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
    Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
    Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
    Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
    Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized open label trial.
    Algara López M; Rodríguez García E; Beato Tortajada I; Martínez Arcelus FJ; Salinas Ramos J; Rodríguez Garrido JR; Sanz Latiesas X; Soler Rodríguez A; Juan Rijo G; Flaquer García A
    Radiat Oncol; 2020 Oct; 15(1):229. PubMed ID: 33008422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.
    Poortmans PM; Collette S; Kirkove C; Van Limbergen E; Budach V; Struikmans H; Collette L; Fourquet A; Maingon P; Valli M; De Winter K; Marnitz S; Barillot I; Scandolaro L; Vonk E; Rodenhuis C; Marsiglia H; Weidner N; van Tienhoven G; Glanzmann C; Kuten A; Arriagada R; Bartelink H; Van den Bogaert W;
    N Engl J Med; 2015 Jul; 373(4):317-27. PubMed ID: 26200978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.
    Kim YB; Byun HK; Kim DY; Ahn SJ; Lee HS; Park W; Kim SS; Kim JH; Lee KC; Lee IJ; Kim WT; Shin HS; Kim K; Shin KH; Nam CM; Suh CO
    JAMA Oncol; 2022 Jan; 8(1):96-105. PubMed ID: 34695841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
    Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
    BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.
    Hennequin C; Bossard N; Servagi-Vernat S; Maingon P; Dubois JB; Datchary J; Carrie C; Roullet B; Suchaud JP; Teissier E; Lucardi A; Gerard JP; Belot A; Iwaz J; Ecochard R; Romestaing P
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):860-6. PubMed ID: 23664327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.
    Chatterjee S; Chakraborty S;
    Trials; 2020 Sep; 21(1):819. PubMed ID: 32998747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysis.
    Haussmann J; Budach W; Tamaskovics B; Bölke E; Corradini S; Djiepmo-Njanang FJ; Kammers K; Matuschek C
    Radiat Oncol; 2019 Jun; 14(1):102. PubMed ID: 31186015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.